Conmed Q2 sales, adjusted profit beat on organinc platform growth

Conmed

29/07/2026 21:34

Overview
U.S. medical device maker's Q2 sales rose 0.3%, beating analyst expectations
Adjusted EPS for Q2 climbed 20% and beat analyst expectations
Company updated 2026 guidance after organic growth in core surgery lines

Outlook
CONMED sees 2026 net sales between $1.358 bln and $1.373 bln
Company expects 2026 adjusted diluted EPS of $4.48 to $4.60
CONMED updates guidance to reflect second qtr performance and outlook for second half

Result Drivers
PORTFOLIO OPTIMIZATION - Co said organic sales growth was driven by exits from GI product lines as part of its portfolio optimization strategy
GROWTH PLATFORMS - Year-over-year organic growth in Orthopedic Surgery and General Surgery lines attributed to focus on AirSeal, Buffalo Filter, and BioBrace platforms
TARIFF REFUNDS - Q2 adjusted EPS included a $0.21 per share benefit from IEEPA tariff refunds

Company press release: ID:nBw43Y2CWa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Beat
$343.49 mln
$337.56 mln (7 Analysts)
Q2 Adjusted EPS
Beat
$1.38
$1.11 (7 Analysts)
Q2 EPS
 
$0.77
 
Q2 Net Income
 
$23.07 mln
 
Q2 Income from Operations
 
$36.41 mln
 
Q2 Pretax Profit
 
$31.35 mln
 

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Conmed Corp is $39.00, about 11.9% below its July 28 closing price of $44.25
The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 8 three months ago

Reuters Recommended Reads
July 29 - Integra LifeSciences Q2 revenue slightly beats, adjusted EPS tops estimates
July 29 - Bausch + Lomb Q2 revenue beats on surgical segment growth; lifts outlook
July 29 - Boston Scientific trims annual profit forecast on softer Watchman device demand

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)